These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6280584)

  • 21. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrate-induced impairment of neuromuscular transmission in human and experimental autoimmune myasthenia gravis.
    Wirguin I; Brenner T; Shinar E; Argov Z
    Ann Neurol; 1990 Mar; 27(3):328-30. PubMed ID: 2158269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional curare test in the study of neuromuscular transmission in hyperthyroidism.
    Witoonpanich R; Vejjajiva A; Limpisvasti S
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():187-91. PubMed ID: 2543726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new regional curare test of the elbow flexors in myasthenia gravis.
    Horowitz SH; Krarup C
    Muscle Nerve; 1979; 2(6):478-90. PubMed ID: 514314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is excitation-contraction coupling impaired in myasthenia gravis?
    Nakata M; Kuwabara S; Kawaguchi N; Takahashi H; Misawa S; Kanai K; Tamura N; Sawai S; Motomura M; Shiraishi H; Takamori M; Maruta T; Yoshikawa H; Hattori T
    Clin Neurophysiol; 2007 May; 118(5):1144-8. PubMed ID: 17307394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis.
    Milner-Brown HS; Miller RG
    J Neurol Sci; 1982 Dec; 57(2-3):357-68. PubMed ID: 6298372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 29. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis.
    Pagala M; Nandakumar NV; Venkatachari SA; Ravindran K; Amaladevi B; Namba T; Grob D
    Muscle Nerve; 1993 Sep; 16(9):911-21. PubMed ID: 8355722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The staircase phenomenon in myasthenia gravis and other neuromuscular disorders (author's transl)].
    Meienberg O; Ludin HP
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1977 Dec; 8(4):192-4. PubMed ID: 412656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmapheresis in the treatment of myasthenia gravis.
    Lenzhofer R; Graninger W; Dittrich C; Mamoli B; Zeitlhofer J; Pateisky K
    Wien Klin Wochenschr; 1983 Apr; 95(8):266-71. PubMed ID: 6603717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
    Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presynaptic changes of neuromuscular transmission in mice induced by passive transfer of plasma with anti-presynaptic membrane receptor antibodies from a patient with myasthenia gravis.
    Xu K; Shu XQ; Zhuo XL; Lu CZ
    J Peripher Nerv Syst; 1998; 3(2):103-9. PubMed ID: 10959243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models.
    Plomp JJ; Morsch M; Phillips WD; Verschuuren JJ
    Exp Neurol; 2015 Aug; 270():41-54. PubMed ID: 25620417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudoselectivity of the neuromuscular block in ocular myasthenia: a SFEMG study.
    Emeryk B; Rowińska-Marcińska K; Nowak-Michalska T
    Electromyogr Clin Neurophysiol; 1990 Jan; 30(1):53-9. PubMed ID: 2154369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients.
    Rostedt A; Padua L; Stålberg EV
    Clin Neurophysiol; 2005 Sep; 116(9):2058-64. PubMed ID: 16043394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.